Lycia Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-25.
Lycia Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 25, 2026. Lycia Therapeutics, Inc. trades on Nasdaq as LYCA. The filing reports $75M sold. Its industry group is Biotechnology. It names William Rieflin (Director), Clare Ozawa (Director), Ming Fang (Director) (SEC Form D, June 25, 2026).
Who owns Lycia Therapeutics, Inc.?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Lycia Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-06-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lycia Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Lycia Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in June 2026, largest first.
Get an email when Lycia Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lycia Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Lycia Therapeutics, Inc. →Get the full cited report on Lycia Therapeutics, Inc.
What the filing shows about Lycia Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lycia Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lycia Therapeutics, Inc.'s address as 400 East Jamie Court, Suite 200, South San Francisco, CA 94080.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Lycia Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Lycia Therapeutics, Inc. See pricing
Lycia Therapeutics, Inc. is a registered filer with the SEC (CIK 1806540) and has filed since 2024-05-23. 2 filings are on record, the latest on 2026-06-25.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lycia Therapeutics, Inc.'s Form D of 2026-06-25 names William Rieflin, Clare Ozawa, Ming Fang and 4 more as its officers, directors or promoters.
Its new offerings report $181.60M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $75M, on the same scale — one filing against the whole group's total, so it sits low by construction.
William Rieflin is named as Director on the Form D that Lycia Therapeutics, Inc. filed with the SEC on 25 June 2026, one of 7 people that filing names.
Clare Ozawa is named as Director on the Form D that Lycia Therapeutics, Inc. filed with the SEC on 25 June 2026, one of 7 people that filing names.
Ming Fang is named as Director on the Form D that Lycia Therapeutics, Inc. filed with the SEC on 25 June 2026, one of 7 people that filing names.
Laurent Fischer is named as Director on the Form D that Lycia Therapeutics, Inc. filed with the SEC on 25 June 2026, one of 7 people that filing names.
Tim Anderson is named as Director on the Form D that Lycia Therapeutics, Inc. filed with the SEC on 25 June 2026, one of 7 people that filing names.
Aetna Wun Trombley is named as Executive Officer and Director on the Form D that Lycia Therapeutics, Inc. filed with the SEC on 25 June 2026, one of 7 people that filing names.
Amy Bachrodt is named as Executive Officer on the Form D that Lycia Therapeutics, Inc. filed with the SEC on 25 June 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-06-25 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Lycia Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lycia Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lycia Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lycia Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lycia Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Lycia Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/lycia-therapeutics-inc-form-d-26000001